USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 30,000 shares of the stock in a transaction on Tuesday, December 4th. The stock was sold at an average price of $120.56, for a total value of $3,616,800.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of NYSE USNA opened at $120.09 on Friday. USANA Health Sciences, Inc. has a 12-month low of $69.55 and a 12-month high of $137.95. The firm has a market capitalization of $2.86 billion, a P/E ratio of 29.58 and a beta of 0.79.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, October 23rd. The company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.14. USANA Health Sciences had a return on equity of 29.67% and a net margin of 7.57%. The firm had revenue of $296.80 million during the quarter, compared to the consensus estimate of $289.54 million. During the same period in the prior year, the firm earned $1.03 EPS. The firm’s quarterly revenue was up 13.4% compared to the same quarter last year.

USANA Health Sciences announced that its Board of Directors has initiated a stock repurchase plan on Tuesday, October 23rd that authorizes the company to repurchase $150.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 5.9% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s management believes its shares are undervalued.

USNA has been the topic of several research reports. ValuEngine lowered USANA Health Sciences from a “buy” rating to a “hold” rating in a research report on Thursday, November 8th. Pivotal Research upgraded USANA Health Sciences from a “hold” rating to a “buy” rating and set a $135.00 price target for the company in a report on Wednesday, October 24th. Finally, Sidoti upgraded USANA Health Sciences from a “neutral” rating to a “buy” rating in a report on Thursday, October 25th.

A number of hedge funds and other institutional investors have recently made changes to their positions in USNA. California Public Employees Retirement System grew its stake in shares of USANA Health Sciences by 6.4% during the second quarter. California Public Employees Retirement System now owns 22,550 shares of the company’s stock valued at $2,600,000 after acquiring an additional 1,366 shares in the last quarter. NEXT Financial Group Inc acquired a new stake in shares of USANA Health Sciences during the third quarter valued at about $121,000. Swiss National Bank grew its stake in shares of USANA Health Sciences by 6.6% during the second quarter. Swiss National Bank now owns 20,900 shares of the company’s stock valued at $2,410,000 after acquiring an additional 1,300 shares in the last quarter. Capital Fund Management S.A. acquired a new stake in shares of USANA Health Sciences during the second quarter valued at about $473,000. Finally, Bank of New York Mellon Corp grew its stake in shares of USANA Health Sciences by 22.4% during the second quarter. Bank of New York Mellon Corp now owns 112,111 shares of the company’s stock valued at $12,926,000 after acquiring an additional 20,510 shares in the last quarter. Hedge funds and other institutional investors own 54.53% of the company’s stock.

WARNING: “Myron W. Wentz Sells 30,000 Shares of USANA Health Sciences, Inc. (USNA) Stock” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.dailypolitical.com/2018/12/08/myron-w-wentz-sells-30000-shares-of-usana-health-sciences-inc-usna-stock.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.

Featured Story: Systematic Risk and Investors

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.